Average Insider

Where insiders trade, we follow

$IQV
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with HealthCore, Inc. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.
Healthcare
Sector
Medical - Diagnostics & Research
Industry
Ari Bousbib
CEO
89000
Employees
$271.11
Current Price
$28.00B
Market Cap
52W Low$154.50
Current$271.1189.7% above low, 10.3% below high
52W High$284.50

Insider Activity Statistics

Aggregated buying and selling activity by time period
PeriodTypeInsidersTransactionsValueSharesBuy/Sell Ratio
1 weekBuys00---
Sells00--
2 weeksBuys00--All Sells
Sells11$1,239,678.184,446
1 monthBuys00--All Sells
Sells11$1,239,678.184,446
2 monthsBuys00--All Sells
Sells11$1,239,678.184,446
3 monthsBuys00--All Sells
Sells22$1,936,906.627,114
See activity going back 12 months โ€” create a free account

Insider Transactions

Recent purchases and sales by company insiders
DateInsiderTypeSharesPriceValueActions
Nov 9, 2026
Sherbet Eric
Executive Vice President, General Counsel
Sale4,446$278.83$1,239,678.18View Details
Sep 2, 2026
Berkshire James G.
EVP, Global Infrastructure and Operations. Power of Attorney
Sale2,668$261.33$697,228.44View Details
9 more transactions available โ€” create a free account to see 12 months of history

Upcoming Earnings

Scheduled earnings reports
No upcoming earnings scheduled

Past Earnings

Historical earnings results
Oct 27, 2026
EPS
Estimated$3.25
ActualN/A
Revenue
Estimated$4.37B
ActualN/A
2 more earnings records available โ€” create a free account to see 12 months of history
Version: v26.10.12